Trial Profile
Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Aug 2021
Price :
$35
*
At a glance
- Drugs Pneumococcal 13-valent CRM197 vaccine conjugate (Primary) ; Pneumococcal vaccine (Primary)
- Indications Pneumococcal infections
- Focus Pharmacodynamics
- Acronyms HYPOPNEUMO
- 31 Jul 2021 Status changed from active, no longer recruiting to completed.
- 25 Aug 2015 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 06 Nov 2014 New trial record